ÂÜÀòÂÒÂ×

Dr. Andersson has a background in medicinal chemistry, synthetic organic chemistry, drug discovery and drug development and is particularly knowledgeable in cardiovascular-gastrointestinal diseases and central nervous system (CNS). He is currently a chemistry consultant and founder of KemiKAN. Prior to this, he has held various executive positions within drug discovery such as acting Head of Medicinal Chemistry at AstraZeneca Mölndal but is also the inventor of the drugs Tesaglitazar (GALIDA) and Clevidipine (CLEVIPREX). Dr. Andersson holds a Ph.D. in Physical Organic Chemistry from the University of Gothenburg, Sweden.